DDI (DRUG-DRUG INTERACTION)
Clinical trials for DDI (DRUG-DRUG INTERACTION) explained in plain language.
Never miss a new study
Get alerted when new DDI (DRUG-DRUG INTERACTION) trials appear
Sign up with your email to follow new studies for DDI (DRUG-DRUG INTERACTION), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new gout Drug's safety with common treatment
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a new gout drug, ABP-671, interacts with the standard medication allopurinol when taken together. It will involve about 20 adults with gout who are already taking stable allopurinol therapy. The main goal is to measure drug levels in …
Matched conditions: DDI (DRUG-DRUG INTERACTION)
Phase: PHASE1 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Knowledge-focused
Last updated Apr 02, 2026 05:57 UTC
-
Scientists test drug mix safety for liver patients
Knowledge-focused Not yet recruitingThis early study aims to understand how a new drug for liver scarring (hydronidone) interacts with four common hepatitis B medications when taken together. Researchers will measure drug levels in the blood of 64 healthy Chinese volunteers to see if the drugs affect each other. Th…
Matched conditions: DDI (DRUG-DRUG INTERACTION)
Phase: PHASE1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC